Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara Hero

Showing results (51-60 of 141) with videos related to

Pageof 15
Sort By:
Nature Genetics|March 27, 2023
Neuroblastoma arises in early fetal development and its evolutionary duration predicts outcomeVerena Körber, Sabine A Stainczyk, Roma Kurilov, et al.
Cancer Letters|June 1, 2005
Opsoclonus myoclonus syndrome in neuroblastoma a report from a workshop on the dancing eyes syndrome at the advances in neuroblastoma meeting in Genoa, Italy, 2004Katherine K Matthay, Franz Blaes, Barbara Hero, et al.
Annals of Neurology|July 1, 2005
Surface-binding autoantibodies to cerebellar neurons in opsoclonus syndromeFranz Blaes, Verena Fühlhuber, Martina Korfei, et al.
BMC Cancer|August 6, 2017
Complete surgical resection improves outcome in INRG high-risk patients with localized neuroblastoma older than 18 monthsJanina Fischer, Alexandra Pohl, Ruth Volland, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 21, 2010
Polo-like kinase 1 is a therapeutic target in high-risk neuroblastomaSandra Ackermann, Felix Goeser, Johannes H Schulte, et al.
Pediatric Blood & Cancer|April 5, 2021
NeuroblastomaChristine Chung, Tom Boterberg, John Lucas, et al.
Pediatric Blood & Cancer|January 18, 2007
Treatment of neuroblastoma-related opsoclonus-myoclonus-ataxia syndrome with high-dose dexamethasone pulsesFlorian Ertle, Wolfgang Behnisch, Naima Ali Al Mulla, et al.
Genes, Chromosomes & Cancer|September 8, 2006
Oligonucleotide array-based comparative genomic hybridization (aCGH) of 90 neuroblastomas reveals aberration patterns closely associated with relapse pattern and outcomeRuediger Spitz, Andre Oberthuer, Marc Zapatka, et al.
Cancer Genetics and Cytogenetics|May 10, 2006
Favorable outcome of triploid neuroblastomas: a contribution to the special oncogenesis of neuroblastomaRuediger Spitz, David R Betts, Thorsten Simon, et al.
Studies in Health Technology and Informatics|September 1, 2016
IT Infrastructure for Merging Data from Different Clinical Trials and Across Independent Research NetworksDieter Hayn, Markus Falgenhauer, Martin Kropf, et al.
Pageof 15

Showing results (51-60 of 141) with videos related to

Sort By:
Pageof 15
Nature Genetics|March 27, 2023
Neuroblastoma arises in early fetal development and its evolutionary duration predicts outcomeVerena Körber, Sabine A Stainczyk, Roma Kurilov, et al.
Cancer Letters|June 1, 2005
Opsoclonus myoclonus syndrome in neuroblastoma a report from a workshop on the dancing eyes syndrome at the advances in neuroblastoma meeting in Genoa, Italy, 2004Katherine K Matthay, Franz Blaes, Barbara Hero, et al.
Annals of Neurology|July 1, 2005
Surface-binding autoantibodies to cerebellar neurons in opsoclonus syndromeFranz Blaes, Verena Fühlhuber, Martina Korfei, et al.
BMC Cancer|August 6, 2017
Complete surgical resection improves outcome in INRG high-risk patients with localized neuroblastoma older than 18 monthsJanina Fischer, Alexandra Pohl, Ruth Volland, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 21, 2010
Polo-like kinase 1 is a therapeutic target in high-risk neuroblastomaSandra Ackermann, Felix Goeser, Johannes H Schulte, et al.
Pediatric Blood & Cancer|April 5, 2021
NeuroblastomaChristine Chung, Tom Boterberg, John Lucas, et al.
Pediatric Blood & Cancer|January 18, 2007
Treatment of neuroblastoma-related opsoclonus-myoclonus-ataxia syndrome with high-dose dexamethasone pulsesFlorian Ertle, Wolfgang Behnisch, Naima Ali Al Mulla, et al.
Genes, Chromosomes & Cancer|September 8, 2006
Oligonucleotide array-based comparative genomic hybridization (aCGH) of 90 neuroblastomas reveals aberration patterns closely associated with relapse pattern and outcomeRuediger Spitz, Andre Oberthuer, Marc Zapatka, et al.
Cancer Genetics and Cytogenetics|May 10, 2006
Favorable outcome of triploid neuroblastomas: a contribution to the special oncogenesis of neuroblastomaRuediger Spitz, David R Betts, Thorsten Simon, et al.
Studies in Health Technology and Informatics|September 1, 2016
IT Infrastructure for Merging Data from Different Clinical Trials and Across Independent Research NetworksDieter Hayn, Markus Falgenhauer, Martin Kropf, et al.
Pageof 15